Blog - Page 2 of 6 - Boardroom Buzz

Transatlantic Underwriters Launches New Property & Casualty Insurance Division

Insurance

Staff Writer

-

April 24, 2025

Transatlantic Underwriters Launches New Property & Casualty Insurance Division

Transatlantic Underwriters (TAU), a leader in specialty insurance for the transportation industry, announces the launch of a new Property & Casualty (P&C) division to expand service offerings while maintaining a strong commitment to transportation clients.

Bernadette Flores, TAU Senior Vice President of Property and Casualty

The strategic expansion introduces six new lines of business: Commercial General & Excess Liability, Commercial Property, Inland Marine, Builders Risk, and Garage. This move represents a significant evolution for TAU, which began as a three-person operation in 1989 and has grown significantly in recent years, with continued growth on the horizon.

“Since founding TAU, I’ve always envisioned expanding beyond our transportation specialty when the timing was right,” said Colby Waltenburg, President of Transatlantic Underwriters. “Our transportation operations are thriving, and we’re now positioned to diversify our offerings to better serve existing customers and welcome new partners. This expansion strengthens our organization while maintaining our commitment to exceptional service in the transportation space.”

To lead this new division, TAU has appointed Bernadette Flores as Senior Vice President of Property & Casualty. Flores brings over 24 years of experience in the excess and surplus P&C sector, with particular expertise in Contractors, Garage, Habitational, and Hospitality.

“I’ve known Colby for over 20 years and have always admired TAU’s approach to specialty insurance,” said Flores. “The opportunity to build a new division from the ground up is something I’ve aspired to accomplish during my career. I’m incredibly thankful and excited to lead this initiative, bringing TAU’s reputation for excellence to these new lines of business.”

Flores will operate from TAU’s San Francisco Bay Area office, where she began her new role in early April 2025.

The company noted that website updates reflecting the new lines of business will be implemented soon, providing detailed information about the expanded offerings. Visit tau-usa.com in the coming weeks for more insight.

About Transatlantic Underwriters
Transatlantic Underwriters (TAU) is a specialized wholesale insurance brokerage that has been providing competitive pricing, stellar service, and coverage for unique risks since 1989. With a foundation of excellence in transportation insurance and now expanding into Property & Casualty lines, TAU combines industry expertise with personalized service to protect businesses nationwide.

NSM Insurance Group Announces Completion of Transaction with New Mountain Capital

Insurance

Staff Writer

-

April 23, 2025

0

NSM Insurance Group Announces Completion of Transaction with New Mountain Capital

NSM Insurance Group (“NSM”), a global specialty insurance provider, announced today it has completed the sale of its U.S. commercial insurance division to New Mountain Capital (“New Mountain”), a leading growth-oriented investment firm with over $55 billion in assets under management.

The agreement encompasses NSM’s diverse portfolio of 15 market-leading niche insurance programs across Property & Casualty, Accident & Health and Reinsurance — as well as its retail agency, NSM Insurance Brokers.

As the NSM business evolves into two separate entities as a result of the sale, new brands will be announced shortly for both the U.S. commercial division and the company’s remaining direct-to-consumer insurance brands.

As a result of the transaction, Geof McKernan and Bill McKernan have joined the board of directors for the new entity backed by New Mountain, and Aaron Miller, Chief Commercial Lines Officer at NSM, has been appointed as Chief Executive Officer, effective immediately.

Geof McKernan, NSM’s Founder commented, “We are extremely pleased to complete the transaction with New Mountain and I’m confident they are the perfect partner to accelerate the growth of the business as they embark on this next chapter of the company’s evolution and deliver significant value to the team and its partners and customers.”

Robert Mulcare, Managing Director, and Sean Donovan, Director at New Mountain Capital, added, “We are excited about this milestone and look forward to collaborating with Aaron and the team to build the business into the leading independent commercial insurance MGA, recognized for its exceptional team, innovation and specialty solutions.”

About NSM Insurance Group
NSM Insurance Group is a global specialty insurance provider, exclusively focused on building successful insurance programs. For more than 30 years, NSM has been committed to delivering industry-specific insurance programs that help agents meet the unique needs of their customers and fuel market growth through innovative development, underwriting, distribution and risk management expertise. The company has built more than $2 billion in premium across 30+ specialty insurance programs and brands around the world focused on collector cars; student health and travel; social services and behavioral health; addiction treatment; coastal condominiums; towing and garage; trucking; sports and fitness; professional liability for architects and engineers, lawyers, CPAs and doctors; habitational; community association management; commercial and residential contractors; staffing; workers’ compensation; medical stop-loss and managed care; and facultative reinsurance. For more information on NSM, visit nsminc.com.

About New Mountain Capital
New Mountain Capital is a New York-based investment firm that emphasizes business building and growth, rather than excessive risk, as it pursues long-term capital appreciation. The firm currently manages private equity, strategic equity, credit, and net lease real estate funds with nearly $55 billion in assets under management. New Mountain seeks out what it believes to be the highest quality growth leaders in carefully selected industry sectors and then works intensively with management to build the value of these companies. For more information, visit www.newmountaincapital.com.

Elm AI Secures $2 Million to Revolutionize Supply Chain Sustainability and Performance in Oversubscribed Round

Staff Writer

-

April 22, 2025

0

Elm AI Secures $2 Million to Revolutionize Supply Chain Sustainability and Performance in Oversubscribed Round

Elm AI, a Cornell University spinout and an AI-driven platform helping enterprises improve sustainability and operational performance across their supply chains, has successfully raised $2 million in an oversubscribed funding round. The round was led by Beta Boom Fund and Working Capital Fund, with participation from Boro Capital Partners, Very Serious Ventures, Gorges Ventures, The Bond Collective, and Textbook Ventures.

Global enterprises continue to face escalating costs and complexity in supplier due diligence and compliance management, driven by rapidly evolving regulatory standards. Elm AI’s advanced AI-driven technology streamlines this process by automating analysis of supplier documentation (questionnaires, audit reports, etc), and instantly providing actionable insights and recommendations—dramatically faster and more cost-effectively than traditional methods.

Elm AI’s software is already trusted by a diverse range of customers, from mid-sized apparel brands to publicly listed multinational corporations generating billions in revenue. The platform currently manages data from several thousand factories globally. Amongst the company’s first few customers is Reformation, a leading sustainability clothing brand.

“Elm AI has been instrumental in transforming our responsible sourcing process, streamlining cumbersome administrative tasks and giving brands more time to focus on what matters most — building programs and management systems that benefit workers by ensuring safe, healthy, and equitable working conditions.”

– Carrie Freiman Parry, Senior Director Of Sustainability at Reformation

The company was founded in 2023 at Cornell University by Advait Raykar, Aparajita Thakker, Ken He, and Eesha Khanna. Elm AI was built on cutting-edge research of AI applications in the sustainability space, and initially secured funding from Cornell University and Entrepreneurs Roundtable Accelerator. Since then, the company has grown exponentially.

“The Elm AI team’s maturity and focus on solving customer problems continue to impress me. As someone with a long history in supply chain labor and sustainability, it’s refreshing to see such enthusiasm for making a real difference. They’ve made me a firm believer in AI’s ability to accelerate our efforts to support workers in global supply chains.”

– James McMichael, Founder of ELEVATE Global and Mosaic RSR

The newly raised capital will accelerate Elm AI’s growth, allowing the company to quickly onboard customers from its extensive waitlist and continue expanding its technological capabilities. Elm AI aims to become the definitive platform for managing comprehensive supplier performance and risk data at global scale.

About Elm AI

Elm AI provides an AI-driven system of record for supplier sustainability, performance, and risk data. The platform automates complex workflows, empowering companies to achieve unprecedented efficiency and sustainability in their supply chain operations.

For more information, visit www.elm-ai.com or contact info@elm-ai.com.

Critical Links Launches an Educational Solution with AI Tailored for Resource-Limited Environments

Tech

Staff Writer

-

April 21, 2025

0

Critical Links Launches an Educational Solution with AI Tailored for Resource-Limited Environments

Critical Links, the leader in educational micro-cloud e-learning solutions, has released version 6.0 of its C3 Micro-Cloud, which puts the power of AI-based learning in classrooms around the world — even in areas with unstable connectivity, limited infrastructure, or restricted access to electricity. This new capability allows AI-powered large language models (LLMs) to operate locally, ensuring a secure and cost-effective digital learning experience anywhere without requiring expensive cloud resources. With this release, the company is the first edtech provider to address one of the most pressing challenges in education today: ensuring that every teacher and student can benefit from AI, regardless of their environment or access to the internet.

Version 6.0 of the C3 Micro-Cloud introduces the SAFE AI model, a set of principles designed to ensure that AI provides tangible benefits to students, regardless of their context:

S-ecure – An AI-enabled digital learning environment where sensitive information is protected from leakage, while unsafe data is blocked from entering; this ensures a safe space for students to learn, free from the risk of exposure or external interference.
A-ppropriate – Ensures that the content used is pedagogically and culturally appropriate, respecting each student’s level of understanding and cultural specificities, guided by “guardrails” that ensure only appropriate content, both in terms of understanding level and cultural aspects, is included in AI-based interactions.
F-unctionally Specific – Applies role-based prompt engineering, guardrails, and a tailored conversational user interface that addresses specific tasks, requests, and desired outcomes of user types ensuring results are not only appropriate but also effective in achieving the desired objectives.
E-conomically Feasible – With full offline capabilities, the C3 Micro-Cloud 6.0 ensures that all students, even those in regions with limited infrastructure, can access cutting-edge technology at a cost of only pennies per student per day without requiring cloud or datacenter access; – the result is high-quality AI interaction for students and teachers anywhere without requiring additional infrastructure investment.

To bring the benefits of the SAFE model to life, the C3 Micro-Cloud 6.0 includes a suite of powerful, AI-driven tools specifically designed to streamline teaching tasks and create more dynamic, personalized learning experiences for students. These tools are fully functional offline, ensuring a secure and effective learning environment, while making it easier for educators to manage, track, and support student progress efficiently:

Lesson Planner – Automatically generates structured lesson plans.
Topic Explainer – Supports the preparation of complex or unfamiliar topics.
Quiz Generator – Quickly creates ready-to-use quizzes and tests.
Study Planner – Organizes personalized study plans based on classroom content.
Proofreader – Automatically reviews and corrects student texts, reducing teachers’ workload.
Text Translation – Enables translation of texts in offline environments.

Charles Foley, Chairman of Critical Links, also commented on the project: “By putting AI at the fingertips of teachers and students anywhere in the world – but in a SAFE manner – we ensure that every student in the world can have access to an AI-enabled learning experience without technical or financial burden. The launch of version 6.0 of the C3 Micro-Cloud is a significant step in democratizing the learning experience worldwide, and is essential for preparing tomorrow’s global workforce no matter where they live.”

This technological breakthrough has drawn the attention of industry leaders such as Intel, who worked with the company to achieve the integration of Intel Core Ultra Processors into the C3 Micro-Cloud to power these AI workloads. This collaboration ensures high-performance, local AI capabilities — even in fully offline classroom settings.

“Critical Links’ Micro-Cloud represents a significant step forward in educational technology, offering a solution that is both innovative and inclusive. By enhancing learning experiences offline, they are setting a new standard for accessible education,” said Michael A. Campbell, Senior Director at Intel.

As technology continues to evolve, Critical Links remains committed to making quality education accessible for everyone, ensuring that every student, no matter where they are, has the tools they need to succeed in the classroom and beyond. More information is available at www.critical-links.com/aisolution

About Critical Links

Critical Links is a pioneer in delivering innovative ICT infrastructure solutions for the next generation of schools, focusing on economically enabling e-learning in challenging environments. The C3 Cloud Control is a groundbreaking solution that creates an autonomous and self-sufficient learning environment. This platform enables educational institutions to access and manage learning management systems, curricula, and digital resources, even in areas with limited or no connectivity. With its offline capability, C3 Cloud Control ensures that students and teachers have continuous access to high-quality educational content, fostering education in remote and underserved regions. More information can be found at http://critical-links.com. Please contact sales@critical-links.com for further information on Critical Links, its education portfolio, and pricing.

Voiant Acquires Voxeleron to Expand Ophthalmic Clinical Research with AI Technology

Staff Writer

-

April 20, 2025

0

Voiant Acquires Voxeleron to Expand Ophthalmic Clinical Research with AI Technology

Voiant, a leader in clinical trial imaging solutions, today is announcing the acquisition of Voxeleron, a pioneering company in AI-driven ophthalmic image analysis. This strategic acquisition marks a significant advancement in Voiant’s mission to accelerate the development of innovative treatments for eye diseases.

Voiant’s extensive ophthalmic clinical trial expertise coupled with Voxeleron’ s cutting-edge technology will drive the next generation of imaging solutions for clinical research in ophthalmology. This synergy offers the best of both worlds: proven and trusted scientific and operational expertise in ophthalmic research coupled with AI-enhanced image analysis and technology. Our integrated platform now offers unmatched capabilities in ophthalmology, including advanced AI-driven insights for retinal and corneal imaging. This integration enables deeper clinical insights, improves data accuracy and accelerates the development of innovative treatments, hastening their delivery to patients in need.

Jim Primerano, CEO of Voiant, commented, “This acquisition is a strategic leap forward for Voiant. By combining our proven expertise with Voxeleron’s AI-powered innovation, we are setting new standards in ophthalmic clinical research. Our integrated platform will deliver deeper clinical insights, faster timelines, enhanced quality, and cost efficiencies, ultimately benefiting patients in need.”

Jonathan Oakley and Daniel Russakoff, Voxeleron co-founders, added, “We are excited to come together with Voiant. Our advanced AI image analysis capabilities, combined with Voiant’s extensive clinical trial expertise, will change the paradigm in the field of ophthalmology. Together, we will drive innovation and improve patient outcomes.”

Voiant will leverage its newly combined capabilities with continued investment to advance biomarker development and image analysis capabilities at an unparalleled pace. Our global investment in AI/ML development demonstrates our dedication to remaining at the forefront of clinical research innovation.

By leveraging our 30-year legacy of excellence and highlighting new AI-powered capabilities, Voiant positions itself as an innovative yet reliable clinical trial imaging partner.

About Voiant

Voiant is the industry leading AI-based clinical trial imaging solution provider with unparalleled scientific and clinical domain expertise, providing biopharmaceutical companies with high-speed delivery of quality clinical endpoint data.

Additional information is available at www.voiantclinical.com.

About Voxeleron

Voxeleron is a pioneering company in AI-driven ophthalmic image analysis, offering advanced solutions for applications in medicine, biology, and beyond. Voxeleron’s platform provides image analysis software for all ophthalmic imagery, enabling researchers to accelerate clinical research, generate actionable results, and ultimately drive better patient outcomes.

Additional information is available at www.voxeleron.com

Turing Medical Names Transformative Med Tech Leader Kevin King as President and Chief Executive Officer

Life Sciences

Staff Writer

-

April 19, 2025

0

Turing Medical Names Transformative Med Tech Leader Kevin King as President and Chief Executive Officer

Turing Medical, a leader in precision brain mapping and targeting technologies, announced the appointment of Kevin King, former CEO of iRhythm Technologies, Affymetrix and Thomson Reuters Healthcare, as the company’s new President and Chief Executive Officer (CEO). Turing Medical is developing advanced functional connectivity MRI processing techniques with the potential to generate highly detailed, personalized circuit maps that could help in the understanding and treatment of brain disorders.

“Bringing Kevin King on as CEO marks a defining moment for Turing,” said Nico Dosenbach, co-founder of Turing Medical. “As CEO of iRhythm, Kevin built one of the most successful digital health companies of our time—changing the standard of care for millions living with heart conditions. His track record of turning bold ideas into widely adopted clinical solutions makes him the ideal leader to help Turing redefine how we treat serious brain disorders.”

Under King’s leadership, Turing Medical is aiming to launch a clinical trial of its pioneering PACE (Personalized Adaptive Cortical Electro-stimulation) Therapy for Treatment Resistant Depression. This innovative approach integrates the precise targeting capabilities of the Bullsai platform with a novel minimally invasive neuromodulation therapy designed to provide sustainable relief for patients who have not responded to conventional treatments.

Proven Healthcare and Technology Leadership

King brings more than 30 years of leadership experience in healthcare and technology. Most recently, as CEO and president of iRhythm Technologies Inc. (NASDAQ: IRTC), a digital healthcare information services company, he guided the organization from early-stage startup through a successful public offering.

Prior to iRhythm, King served as CEO of Affymetrix Inc. (now part of Thermo Fisher Scientific) and Thomson Reuters Healthcare. King also held a number of senior executive positions in MRI at GE Healthcare and began his career in HP’s Medical Products Group.

“Turing Medical is poised to revolutionize neuroscience and bring hope to millions suffering from devastating neuropsychiatric disorders,” declared King. “The innovative technology developed by Nico Dosenbach and Damien Fair represents the culmination of their lifelong scientific mission. I’m profoundly inspired to help translate their visionary work into transformative therapies that will fundamentally change how we treat brain disorders—potentially restoring lives once thought irrevocably altered by disease.”

Building on Technological Momentum

King joins Turing Medical following a series of significant achievements, including FDA 510(k) clearance for its Bullsai platform—an automated cloud-based system delivering individual brain maps to support neurosurgical planning. Since 2022, the company has successfully marketed its FIRMM and FIRMM-pix MRI motion monitoring software solutions to clinical and research customers.

About Turing Medical

Turing Medical is powering the future of precision neurotechnology, developing game changing solutions that aim to transform how neurological and psychiatric disorders are treated while redefining standards of care through minimally invasive approaches that aim to improve patient outcomes.

For more information, visit Turing Medical Website.

ONTOFORCE’s DISQOVER Chosen by The Michael J. Fox Foundation to Enhance the Integration and Access of Parkinson’s Disease Research Data

Life Sciences

Staff Writer

-

April 18, 2025

0

ONTOFORCE’s DISQOVER Chosen by The Michael J. Fox Foundation to Enhance the Integration and Access of Parkinson’s Disease Research Data

ONTOFORCE, a leader in semantic technology for the life sciences industry, has announced a collaboration with The Michael J. Fox Foundation for Parkinson’s Research (MJFF). DISQOVER, ONTOFORCE’s advanced knowledge discovery platform, will support MJFF’s Targets to Therapies Initiative, a program aimed to expand the number of promising, druggable biological targets within the Parkinson’s disease (PD) translational pipeline. The project will establish a centralized knowledge portal that aggregates, organizes, and visualizes critical data on potential therapeutic targets, reducing barriers to data access and accelerating research processes.

Launched in early 2024, MJFF’s Targets to Therapies Initiative is designed to identify, validate, and de-risk promising biological targets linked to Parkinson’s pathogenesis. A key component of this initiative is the development of an advanced knowledge platform to serve as a central hub for information and data related to promising targets for the Parkinson’s disease research community. DISQOVER will seamlessly integrate disparate data sources to provide an active, evolving list of prioritized targets, a structured scorecard system for ranking targets, access to experimental validation data, and additional resources.

The DISQOVER platform is positioned to support MJFF due to its ability to integrate heterogenous data, track fine-grain data provenance, semantically connect data concepts, and visualize data through an easy-to-use and interactive user interface. Through the Targets to Therapies Initiative, DISQOVER will aggregate relevant target data from public and proprietary sources, standardize and structure data into packages for easy consumption by researchers, and enable insight discovery through dynamic data visualization capabilities. Ultimately, DISQOVER will help remove barriers to data, reduce redundancy, and improve transparency in the Parkinson’s disease research community.

“ONTOFORCE is dedicated to improving data accessibility so that researchers and scientists can focus on the important work that will help drive research forward,” said Valerie Morel, CEO of ONTOFORCE. “By applying DISQOVER’s powerful capabilities to The Michael J. Fox Foundation’s Targets to Therapies Initiative, we are supporting the Parkinson’s disease research community to find and access the target data they need efficiently.”

“Leveraging cutting edge technology in Parkinson’s research and fostering a collaboration with global experts is one of the many ways MJFF works toward unlocking new ideas and paving the way toward new and better treatments into the hands of patients,” said Shalini Padmanabhan, PhD, senior vice president of discovery and translational research at MJFF. “We look forward to partnering with ONTOFORCE and disseminating a consolidated public knowledgebase on emerging therapeutic PD targets in 2025, which will support drug developers and researchers on this critical work of speeding druggable targets.”

About ONTOFORCE

ONTOFORCE helps life sciences organizations accelerate research and drug development by unlocking hidden insights from data. Founded on semantic technology and an ontology-based knowledge graph, their flagship product, DISQOVER, is a knowledge discovery platform developed specifically for the life sciences industry. DISQOVER seamlessly connects an organization’s internal, siloed data with licensed data and public data in one easy-to-use, customizable platform. 

DISQOVER is deployed by many leading pharmaceutical and biotechnology companies. Users include scientific researchers, bioinformaticians, data scientists, and many other roles. ONTOFORCE is headquartered in Ghent, Belgium and has a secondary office in the United States in Cambridge, Massachusetts.

About Targets to Therapies

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) launched Targets to Therapies in 2024 to leverage the global research community’s expertise and characterize previously underexplored, druggable targets for Parkinson’s disease (PD). While a number of high-profile targets like synuclein, GBA and LRRK2 have picked up momentum in the PD space, hundreds more targets remain untapped, offering immense potential for drug development. Targets to Therapies convenes experts from all over the world to push the field forward by characterizing the most promising targets, laying the groundwork for future drug development. The initiative will make its findings public, paving the way for well-informed study in the future. Learn more here.

Lamborghini Club America Debuts Serata Campioni During Monterey Car Week

Automotive

Staff Writer

-

April 17, 2025

0

Lamborghini Club America Debuts Serata Campioni During Monterey Car Week

Lamborghini Club America is rewriting the rules of concours with the debut of Serata Campioni—an all-new celebration of Lamborghini’s bold design, performance legacy, and passionate global community.

Launching during Monterey Car Week 2025, Serata Campioni will take place on Saturday, August 16 from 10 a.m. to 2 p.m. at The Club at Pasadera. This inaugural concours-style event will showcase 63 Lamborghinis—a symbolic tribute to 1963, the year Automobili Lamborghini was founded.

The debut also marks a milestone: the 50th anniversary of Lamborghini Club America, the largest organization of Lamborghini owners and enthusiasts in the world.

“Serata Campioni is more than a car show—it’s a love letter to Lamborghini,” said Joy Loo, co-creator of Serata Campioni and Serata Italiana. “Every detail is designed to honor the champions of the past while inspiring the icons of tomorrow.”

Joy Loo, with her husband Ian Ray, leads the vision behind this new Signature Series event. Known for producing exclusive Lamborghini experiences across the globe, Joy is one of the few women pioneering luxury events at this scale in the automotive world.

The event will highlight a curated lineup of vintage and modern Lamborghinis, each competing for trophy-class titles in a setting that fuses design, heritage, and high-octane excitement.

“Serata Campioni celebrates not only the machines, but the people behind them,” added Andrew Romanowski, President of Lamborghini Club America and longtime collector of a Pebble Beach-winning Lamborghini Miura. “It’s about honoring 50 years of connection, craftsmanship, and shared passion.”

Serata Campioni will be held in conjunction with the exclusive Serata Italiana gala—Lamborghini Club America’s signature sold-out event during Monterey Car Week.

Tickets and competition submissions are now open at SerataItaliana.com. Do you think your Lamborghini has what it takes to compete among champions? Submissions now open—where legends are crowned, and history comes to life.

Greenwich Concours Announces Grand Marshal, Curated Vehicle Classes and Exclusive Reverie Premier Event for Coastal Luxury Showcase

Automotive

Staff Writer

-

April 16, 2025

0

Greenwich Concours Announces Grand Marshal, Curated Vehicle Classes and Exclusive Reverie Premier Event for Coastal Luxury Showcase

The 2025 Greenwich Concours d’Elegance (Friday, May 30 through Sunday, June 1) will once again be hosted at picturesque Roger Sherman Baldwin Park in Greenwich, Connecticut, bringing together automotive enthusiasts and collectors to celebrate the world’s finest cars, luxurious craftsmanship and the spirit of automotive innovation.

“Greenwich Concours is the top automotive event in the Northeast,” said Matt Orendac, Vice Chairman of the Greenwich Concours. “Attendees can look forward to three days of amazing cars, exciting drives and luxury experiences. Like all great concours, it combines the best people and finest cars with an immersive location to kick off the summer season.”

This year, the Greenwich Concours d’Elegance will honor renowned automotive collector Ralph Marano as the Grand Marshal. Marano is celebrated as one of the premier Packard collectors, with a collection of 85 classic models, each one a 100-point, concours quality restoration. Marano is renowned for being the only collector to own a Packard Darrin from every year of manufacture — from 1937 to 1942.

New for 2025, guests will have the opportunity to kick off the weekend festivities with Reverie, held Friday evening. Reverie at Greenwich seamlessly blends the charm of the New England coastline with the sophistication of a world-class luxury event. Guests will enjoy the stunning culinary experience crafted by some of the finest chefs, along with a hosted bar, all set against the charming Greenwich Harbor. The evening unfolds with a lively atmosphere, complete with a DJ spinning smooth rhythms, stylish lounge spaces and an ambiance of effortless sophistication. Don’t miss the chance to experience Reverie’s unique display of coastal luxury, artistry and elegance.

Saturday’s Greenwich Concours de Sport will feature a highly curated selection of sports, racing and supercars representing the epitome of automotive style, performance and innovation. Sunday’s Greenwich Concours d’Elegance builds on a longstanding legacy of excellence, featuring many of the world’s most elegant, important and storied cars. This year’s featured classes for both days are detailed here:

Featured Classes – Concours de Sport – Saturday, May 31

Mid-Engine Revolution	Early Porsche 356’s (Pre-A’s and A’s)
Affordable Ferrari	Resto Mods
Custom Cars of Rob Ida	Race Cars of New England
Classic BMW Coupes	Dealer Performance Cars
VW Transporters	50th Anniversary of Lamborghini Countach
Porsche Powered	Neo Classics
Corvette – Sting Ray 1968-1972	Orphan Cars of the 50’s-60’s
Trans Am Production	Scrambler Saturday (Motorcycles)
Cars of Greenwich Avenue

Featured Classes – Concours d’Elegance – Sunday, June 1

Muscle/Performance – 1960-1972	Post-War German Sports – Mercedes-Benz SL
100 Years of Chrysler	Post-War English Sports
Fast from the Past (Motorcycle)	Post-War Italian Sports
Range Toppers (Motorcycle)	Post-War American Buick Riveria 1963-1973
Supercars	Pre-War European Classics
Porsche Prototypes	Pre-War Classics American
Art Deco Streamliners	Horseless Carriage Glidden Tour Reunion
Pinin Farina	Cars of Donald Healey

Ticket Information:

Readers can find more information and ticket pricing at https://www.greenwichconcours.com/.

About Greenwich Concours

Founded in 1996, Greenwich Concours d’Elegance is a three-day premier motoring event in Greenwich, Conn. Exclusive gatherings, luxury shopping, ride and drives, new vehicle experiences and automotive heritage elements complement Friday’s Grand Tour and Saturday’s Concours de Sport. Sunday’s nationally recognized Concours d’Elegance celebrates historically significant American and International vehicles along the town’s picturesque harbor front. Each year the event supports local charities as a part of Hagerty’s larger giving strategy. For more about the Greenwich Concours d’Elegance visit our website at GreenwichConcours.com.

About Hagerty, Inc. (NYSE: HGTY)

Hagerty is an automotive enthusiast brand committed to saving driving and to fueling car culture for future generations. The company is a leading provider of specialty vehicle insurance, expert car valuation data and insights, live and digital car auction services, immersive events and automotive entertainment custom made for the 67 million Americans who self-describe as car enthusiasts. Hagerty also operates in Canada and the U.K. and is home to Hagerty Drivers Club, a community of over 875,000 who can’t get enough of cars. For more information, please visit www.hagerty.com or connect with us on Facebook, Instagram, X and LinkedIn.

Datacise by MMS Wins 2025 Data Breakthrough Award for Best Data Science Solution

Staff Writer

-

April 15, 2025

0

Datacise by MMS Wins 2025 Data Breakthrough Award for Best Data Science Solution

MMS, an award-winning, data-focused Contract Research Organization (CRO), today announces that its innovative Datacise® platform has been named the Overall Data Science Solution of the Year in the 2025 Data Breakthrough Awards. Datacise is an innovative, cloud-based technology platform that enables biotechnology and pharmaceutical companies to more efficiently curate, analyze, and visualize clinical and real-world data to accelerate decision-making.

The mission of the Data Breakthrough Awards is to honor excellence and recognize the creativity, hard work and success of organizations driving technological advances across industry sectors. The program’s independent judging panel evaluates entries based on criteria such as innovation, performance, user experience, functionality, market impact, and value.

“Earning this award is a tremendous honor for MMS and a clear recognition of the innovative power behind Datacise,” said Mohamad Zahreddine, Chief Information Officer (CIO), MMS. “The vision of our team is paying off through our commitment to delivering advanced, data-driven solutions that address some of the most complex challenges in drug development, including reducing time-to-market, scaling for escalating data volume and variety, and breaking down operational silos.”

Driving Innovation in Data Science with Datacise

Integrated with full-service biometrics solutions at MMS, Datacise equips sponsors with powerful tools that accelerate time to insights, streamline decision-making, and boost productivity across the clinical trial life cycle. Key capabilities of the platform include:

Accelerated Access to Top-Line Data: Significantly reduces the wait time for preliminary clinical trial results, allowing pharmaceutical companies to act quickly on emerging evidence.
Operational Reporting and Streamlined Oversight: Interactive data visualizations allow project team users, including CRAs, to assess clinical trial progress and data quality, respond to issues quickly, and maintain regulatory compliance.
Real-Time Data Views for Data Monitoring Committees (DMCs): Provides safety signal evaluation data the same day, eliminating the need for weeks or months of manual statistical programming.
Enhanced Diversity Planning: Uses geospatial mapping to support the inclusion of diverse patient populations, ensuring clinical trials are both relevant and regulatory compliant.
Improved Trial Adaptability: Supports strategic adjustments mid-study based on early insights, reducing uncertainty and optimizing study outcomes.

“Datacise brings clarity and control to the entire clinical data journey, enhancing efficiency, and empowering teams to move faster with greater confidence,” said Chris Schoonmaker, a statistician by training and Chief Operating Officer (COO) at MMS. “This recognition affirms the value of bringing together focused clinical biometrics services with powerful technology, as well as the combined impact on accelerating drug development.”

The MMS team will be available to discuss the power of Datacise at upcoming conferences including SCDM EMEA in Brussels, Belgium on April 9-11, 2025, and OCT East Coast, King of Prussia, USA on May 20-21, 2025. To arrange a meeting, visit https://mmsholdings.com/contact/. Or, for more information about Datacise and technology-enabled biometrics solutions from MMS, visit www.mmsholdings.com/datacise.

About MMS

MMS Holdings (MMS) is an award-winning, data-focused clinical research organization (CRO) that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience, a 19-year track record, AI technology-enabled services, and a data-driven approach to drug development make MMS a valuable CRO partner. With a global footprint across four continents, MMS maintains an industry-leading customer satisfaction rating.

For more information, visit www.mmsholdings.com.

Boardroom Buzz

NewsWeekPRO

Boardroom Buzz

Boardroom Buzz

Boardroom Buzz

About us

Company

The latest

Subscribe